Selectable gene marker system based on expression of N-acetyllactosaminide 3-.alpha. galactosyltransferase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 18, 2006
Grant Date -
Nov 10, 2005
app pub date -
May 4, 2004
filing date -
May 4, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method is described for the rapid identification and isolation of cells based on the presence or absence of an ectopically-expressed N-acetyllactosaminide 3-.alpha. Galactosyltransferase (.alpha.GT) enzyme for the production of .alpha.Galactosyl-(1,3)Galactosyl (.alpha.Gal) epitopes on the surface of .alpha.Gal-negative cells. These cells which are genetically modified to express the .alpha.GT enzyme and .alpha.Gal epitopes on glycosylated lipids and proteins of the cell surface are then labeled via an antibody composition which recognizes and binds the .alpha.Gal epitopes on the cell surface. Cells labeled with the anti-.alpha.Gal antibody can be isolated by sorting via fluorescence activated cell sorting (FACS), or by magnetic panning techniques. This method is suitable for the rapid positive or negative selection of .alpha.Gal-positive cells from within a population of .alpha.Gal-negative cells without the need to expose cells to antibiotics for any period of time. In addition, the specification provides a method for the production and purification of anti-.alpha.Gal antibodies from chicken egg yolk.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully